Literature DB >> 2845924

Synergism between thrombin and adrenaline (epinephrine) in human platelets. Marked potentiation of inositol phospholipid metabolism.

V M Steen1, O B Tysnes, H Holmsen.   

Abstract

We have studied synergism between adrenaline (epinephrine) and low concentrations of thrombin in gel-filtered human platelets prelabelled with [32P]Pi. Suspensions of platelets, which did not contain added fibrinogen, were incubated at 37 degrees C to measure changes in the levels of 32P-labelled phosphatidylinositol 4,5-bisphosphate (PIP2), phosphatidylinositol 4-phosphate (PIP) and phosphatidate (PA), aggregation and dense-granule secretion after stimulation. Adrenaline alone (3.5-4.0 microM) did not cause a change in any parameter (phosphoinositide metabolism, aggregation and dense-granule secretion), but markedly enhanced the thrombin-induced responses over a narrow range of thrombin concentrations (0.03-0.08 units/ml). The thrombin-induced hydrolysis of inositol phospholipids by phospholipase C, which was measured as the formation of [32P]PA, was potentiated by adrenaline, as was the increase in the levels of [32P]PIP2 and [32P]PIP. The presence of adrenaline caused a shift to the left for the thrombin-induced changes in the phosphoinositide metabolism, without affecting the maximal levels of 32P-labelled compounds obtained. A similar shift by adrenaline in the dose-response relationship was previously demonstrated for thrombin-induced aggregation and dense-granule secretion. Also, the narrow range of concentrations of thrombin over which adrenaline potentiates thrombin-induced platelet responses is the same for changes in phosphoinositide metabolism and physiological responses (aggregation and dense-granule secretion). Our observations clearly indicate that adrenaline directly or indirectly influences thrombin-induced changes in phosphoinositide metabolism.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2845924      PMCID: PMC1149337          DOI: 10.1042/bj2530581

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  35 in total

1.  Novel alpha2-adrenoreceptors primarily responsible for inducing human platelet aggregation.

Authors:  J A Grant; M C Scrutton
Journal:  Nature       Date:  1979-02-22       Impact factor: 49.962

2.  Measurement of inositol phospholipid turnover in platelets.

Authors:  E G Lapetina; W Siess
Journal:  Methods Enzymol       Date:  1987       Impact factor: 1.600

3.  The synergistic effect of serotonin and epinephrine on the human platelet at the level of signal transduction.

Authors:  D de Chaffoy de Courcelles; P Roevens; H Van Belle; F De Clerck
Journal:  FEBS Lett       Date:  1987-07-27       Impact factor: 4.124

4.  Synergistic potentiation by epinephrine of collagen or thrombin-induced calcium mobilization in human platelets.

Authors:  N G Ardlie; L K Bell; J A McGuiness
Journal:  Thromb Res       Date:  1987-05-15       Impact factor: 3.944

5.  Epinephrine inhibits adenylate cyclase and stimulates a GTPase in human platelet membranes via alpha-adrenoceptors.

Authors:  K Aktories; K H Jakobs
Journal:  FEBS Lett       Date:  1981-08-03       Impact factor: 4.124

6.  The influence of Na+ on the alpha 2-adrenergic receptor system of human platelets. A method for removal of extraplatelet Na+. Effect of Na+ removal on aggregation, secretion, and cAMP accumulation.

Authors:  T M Connolly; L E Limbird
Journal:  J Biol Chem       Date:  1983-03-25       Impact factor: 5.157

7.  Dependence of human platelet functional responses on divalent cations: aggregation and secretion in heparin- and hirudin-anticoagulated platelet-rich plasma and the effects of chelating agents.

Authors:  B Lages; H J Weiss
Journal:  Thromb Haemost       Date:  1981-04-30       Impact factor: 5.249

8.  Role of activation in epinephrine-induced aggregation of platelets.

Authors:  H Patscheke
Journal:  Thromb Res       Date:  1980 Jan 1-15       Impact factor: 3.944

9.  Effect of catecholamines on platelet aggregation caused by thrombin.

Authors:  D P Thomas
Journal:  Nature       Date:  1967-07-15       Impact factor: 49.962

10.  Induction of the fibrinogen receptor on human platelets by epinephrine and the combination of epinephrine and ADP.

Authors:  E F Plow; G A Marguerie
Journal:  J Biol Chem       Date:  1980-11-25       Impact factor: 5.157

View more
  6 in total

1.  Heterologous supersensitization between serotonin2 and alpha 2-adrenergic receptor-mediated intracellular calcium mobilization in human platelets.

Authors:  A Kagaya; M Mikuni; H Yamamoto; S Muraoka; S Yamawaki; K Takahashi
Journal:  J Neural Transm Gen Sect       Date:  1992

2.  The inhibition of human platelet function by ganodermic acids.

Authors:  C N Wang; J C Chen; M S Shiao; C T Wang
Journal:  Biochem J       Date:  1991-07-01       Impact factor: 3.857

3.  Evidence for tight metabolic control of the receptor-activated polyphosphoinositide cycle in human platelets.

Authors:  V M Steen; O B Tysnes; H Holmsen
Journal:  Biochem J       Date:  1989-10-15       Impact factor: 3.857

4.  Epinephrine induces changes in the subcellular distribution of the inhibitory GTP-binding protein Gi alpha-2 and a 38-kDa phosphorylated protein in the human platelet.

Authors:  M F Crouch; D A Winegar; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

5.  Phospholipids in Trypanosoma cruzi: phosphoinositide composition and turnover.

Authors:  G Racagni; M García de Lema; C E Domenech; E E Machado de Domenech
Journal:  Lipids       Date:  1992-04       Impact factor: 1.880

6.  Epinephrine suppresses rap1B.GAP-activated GTPase activity in human platelets.

Authors:  K B Marti; E G Lapetina
Journal:  Proc Natl Acad Sci U S A       Date:  1992-04-01       Impact factor: 11.205

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.